More than 1200 of the largest companies in the US have already established more than 1800 on-site clinics to serve the needs of their employees and their families. These clinics have the potential to reshape pharmaceutical sales for years to come. On-site clinics are poised for double-digit growth, and by some estimates could account for over 10% of all pharmaceutical prescriptions written for those under 65 by the year 2015. They will cover both branded and OTC products, and many will have their own pharmacies for immediate dispensing. Most are likely to be linked into sophisticated health management programs, which will be designed to act as high-value compliance programs paid for by the employers. But is this an opportunity or a threat to industry?
Certainly there is the possibility that many of the companies will launch their own formularies, limiting the types of remedies covered. In this audio conference our speakers discuss this new frontier, including who is leading the charge with on-site clinics and what it means for the pharmaceutical industry. As an added bonus, attendees will receive a copy of Fuld’s On-Site Clinics white paper.
On-Site Clinics: Next Big Opportunity or Next Big Threat for Pharma? is being presented by Leonard Fuld & Mike Ratcliffe, Founder & President and Director of Research, with Fuld & Company, Inc. and airs on Thursday, June 11, 2009. For more details or to register for this conference, please visit our site at www.fxconferences.com
